Free Trial

Schmitt Industries (SMIT) Competitors

Schmitt Industries logo
$0.02 0.00 (0.00%)
As of 06/12/2026

SMIT vs. SPEC, TBIO, THMO, HTGMQ, and OLITW

Should you buy Schmitt Industries stock or one of its competitors? MarketBeat compares Schmitt Industries with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Schmitt Industries include Spectaire (SPEC), Telesis Bio (TBIO), ThermoGenesis (THMO), HTG Molecular Diagnostics (HTGMQ), and OmniLit Acquisition (OLITW). These companies are all part of the "measuring and control equipment" industry.

How does Schmitt Industries compare to Spectaire?

Schmitt Industries (NASDAQ:SMIT) and Spectaire (NASDAQ:SPEC) are both small-cap measuring and control equipment companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, institutional ownership, analyst recommendations, media sentiment, earnings, profitability, valuation and dividends.

Schmitt Industries' return on equity of 0.00% beat Spectaire's return on equity.

Company Net Margins Return on Equity Return on Assets
Schmitt IndustriesN/A N/A N/A
Spectaire N/A -81.22%304.57%

26.5% of Spectaire shares are owned by institutional investors. 17.1% of Schmitt Industries shares are owned by company insiders. Comparatively, 25.4% of Spectaire shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Spectaire has lower revenue, but higher earnings than Schmitt Industries.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Schmitt Industries$9.89M0.01-$3.28MN/AN/A
SpectaireN/AN/A$8.95M-$0.30N/A

In the previous week, Schmitt Industries' average media sentiment score of 0.00 equaled Spectaire'saverage media sentiment score.

Company Overall Sentiment
Schmitt Industries Neutral
Spectaire Neutral

Schmitt Industries has a beta of -0.04, indicating that its stock price is 104% less volatile than the broader market. Comparatively, Spectaire has a beta of -6.36, indicating that its stock price is 736% less volatile than the broader market.

Summary

Spectaire beats Schmitt Industries on 4 of the 7 factors compared between the two stocks.

How does Schmitt Industries compare to Telesis Bio?

Telesis Bio (NASDAQ:TBIO) and Schmitt Industries (NASDAQ:SMIT) are both small-cap measuring and control equipment companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, dividends, profitability, analyst recommendations, valuation, risk, institutional ownership and media sentiment.

Schmitt Industries has a net margin of 0.00% compared to Telesis Bio's net margin of -336.59%.

Company Net Margins Return on Equity Return on Assets
Telesis Bio-336.59% N/A -61.89%
Schmitt Industries N/A N/A N/A

Telesis Bio has a beta of 2.27, suggesting that its stock price is 127% more volatile than the broader market. Comparatively, Schmitt Industries has a beta of -0.04, suggesting that its stock price is 104% less volatile than the broader market.

In the previous week, Telesis Bio's average media sentiment score of 0.00 equaled Schmitt Industries'average media sentiment score.

Company Overall Sentiment
Telesis Bio Neutral
Schmitt Industries Neutral

37.6% of Telesis Bio shares are held by institutional investors. 24.5% of Telesis Bio shares are held by insiders. Comparatively, 17.1% of Schmitt Industries shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Schmitt Industries has lower revenue, but higher earnings than Telesis Bio.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Telesis Bio$225.09M0.00-$47.72M-$20.52N/A
Schmitt Industries$9.89M0.01-$3.28MN/AN/A

Summary

Telesis Bio and Schmitt Industries tied by winning 4 of the 8 factors compared between the two stocks.

How does Schmitt Industries compare to ThermoGenesis?

ThermoGenesis (NASDAQ:THMO) and Schmitt Industries (NASDAQ:SMIT) are both small-cap measuring and control equipment companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, dividends, media sentiment, risk, institutional ownership, valuation, earnings and analyst recommendations.

Company Net Margins Return on Equity Return on Assets
ThermoGenesisN/A N/A N/A
Schmitt Industries N/A N/A N/A

Schmitt Industries has higher revenue and earnings than ThermoGenesis.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ThermoGenesis$9.61M0.00-$17.98M-$5.14N/A
Schmitt Industries$9.89M0.01-$3.28MN/AN/A

ThermoGenesis has a beta of 1.13, indicating that its stock price is 13% more volatile than the broader market. Comparatively, Schmitt Industries has a beta of -0.04, indicating that its stock price is 104% less volatile than the broader market.

5.8% of ThermoGenesis shares are owned by institutional investors. 78.0% of ThermoGenesis shares are owned by company insiders. Comparatively, 17.1% of Schmitt Industries shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

In the previous week, ThermoGenesis' average media sentiment score of 0.00 equaled Schmitt Industries'average media sentiment score.

Company Overall Sentiment
ThermoGenesis Neutral
Schmitt Industries Neutral

Summary

ThermoGenesis beats Schmitt Industries on 3 of the 5 factors compared between the two stocks.

How does Schmitt Industries compare to HTG Molecular Diagnostics?

Schmitt Industries (NASDAQ:SMIT) and HTG Molecular Diagnostics (NASDAQ:HTGMQ) are both measuring and control equipment companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, analyst recommendations, valuation, media sentiment, profitability, earnings and risk.

Schmitt Industries has higher revenue and earnings than HTG Molecular Diagnostics.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Schmitt Industries$9.89M0.01-$3.28MN/AN/A
HTG Molecular Diagnostics$6.37M0.00-$21.59M-$2.28N/A

Schmitt Industries has a beta of -0.04, suggesting that its stock price is 104% less volatile than the broader market. Comparatively, HTG Molecular Diagnostics has a beta of 3.06, suggesting that its stock price is 206% more volatile than the broader market.

Company Net Margins Return on Equity Return on Assets
Schmitt IndustriesN/A N/A N/A
HTG Molecular Diagnostics N/A N/A N/A

In the previous week, Schmitt Industries' average media sentiment score of 0.00 equaled HTG Molecular Diagnostics'average media sentiment score.

Company Overall Sentiment
Schmitt Industries Neutral
HTG Molecular Diagnostics Neutral

Summary

Schmitt Industries beats HTG Molecular Diagnostics on 3 of the 4 factors compared between the two stocks.

How does Schmitt Industries compare to OmniLit Acquisition?

OmniLit Acquisition (NASDAQ:OLITW) and Schmitt Industries (NASDAQ:SMIT) are both measuring and control equipment companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, risk, profitability, institutional ownership, media sentiment, dividends, earnings and analyst recommendations.

Company Net Margins Return on Equity Return on Assets
OmniLit AcquisitionN/A N/A N/A
Schmitt Industries N/A N/A N/A

OmniLit Acquisition has higher earnings, but lower revenue than Schmitt Industries.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
OmniLit AcquisitionN/AN/AN/AN/AN/A
Schmitt Industries$9.89M0.01-$3.28MN/AN/A

In the previous week, OmniLit Acquisition's average media sentiment score of 0.00 equaled Schmitt Industries'average media sentiment score.

Company Overall Sentiment
OmniLit Acquisition Neutral
Schmitt Industries Neutral

Summary

Schmitt Industries beats OmniLit Acquisition on 1 of the 1 factors compared between the two stocks.

Get Schmitt Industries News Delivered to You Automatically

Sign up to receive the latest news and ratings for SMIT and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SMIT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SMIT vs. The Competition

MetricSchmitt IndustriesProcess control instruments IndustryIndustrials SectorNASDAQ Exchange
Market Cap$57K$57K$9.57B$12.36B
Dividend YieldN/AN/A3.55%5.66%
P/E RatioN/AN/A25.6524.60
Price / Sales0.010.014,992.64171.61
Price / CashN/AN/A27.5837.92
Price / BookN/AN/A4.776.77
Net Income-$3.28M-$3.28M$793.52M$337.32M
7 Day PerformanceN/AN/A5.27%2.06%
1 Month PerformanceN/AN/A5.64%3.93%
1 Year PerformanceN/AN/A30.93%32.29%

Schmitt Industries Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SMIT
Schmitt Industries
N/A$0.02
flat
N/AN/A$57K$9.89MN/A160
SPEC
Spectaire
N/A$0.00
flat
N/A-54.5%$9KN/AN/A8
TBIO
Telesis Bio
N/A$0.00
flat
N/A-98.0%$2K$225.09MN/A200
THMO
ThermoGenesis
N/A$0.00
flat
N/AN/A$1K$9.61MN/A40
HTGMQ
HTG Molecular Diagnostics
N/AN/AN/AN/A$0.00$6.37MN/A90

Related Companies and Tools


This page (NASDAQ:SMIT) was last updated on 6/15/2026 by MarketBeat.com Staff.
From Our Partners